ERN ReCONNET-SLICC-SLEuro 关于罕见系统性红斑狼疮表现治疗管理的共识(第2部分)
该共识由三个国际SLE专家组组成的国际工作组制定,针对22种额外罕见SLE表现(包括弥漫性肺出血、罕见皮肤/肾脏/神经/胃肠/肌肉骨骼表现等)形成基于专家的治疗策略。77名参与者参与制定,为循证推荐不足的罕见表现提供治疗决策框架。
要点
- 共识覆盖22种罕见SLE表现的治疗策略,包括弥漫性肺出血、罕见皮肤病变、间质性肾炎等。
- 由ERN ReCONNET、SLICC和SLEuro三个专家组联合制定,77名参与者贡献。
- 为循证证据不足的罕见SLE表现提供基于专家的治疗决策框架。
核心结论
- 该共识为22种罕见SLE表现提供了基于专家的治疗策略框架,用于循证推荐不足时的治疗决策。
研究设计与样本
- 国际工作组由三个SLE专家组(ERN ReCONNET、SLICC、SLEuro)组成,77名参与者参与制定22种罕见SLE表现的治疗策略。
主要发现
- 共识覆盖的罕见表现包括弥漫性肺出血、罕见皮肤表现(大疱性狼疮、冻疮样狼疮、肿胀性狼疮、多形红斑、中毒性表皮坏死松解样狼疮)、肾脏表现(间质性肾炎、狼疮足细胞病)、罕见神经表现(舞蹈症、小纤维神经病、紧张症、颅内高压)、罕见胃肠表现(蛋白丢失性肠病、狼疮肝炎、肠假性梗阻、腹膜炎)、肌肉骨骼表现(肌炎、Jaccoud关节病)及其他罕见表现(葡萄膜炎、抗C1酯酶抑制剂抗体所致血管性水肿、间质性膀胱炎、狼疮性乳腺炎)。
临床怎么用
- 临床中对于循证推荐不足的罕见SLE表现,可参考该专家共识的治疗策略进行决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Systemic lupus erythematosus (SLE) guidelines predominantly focus on common major organ involvement. An international taskforce from three SLE expert groups (European Reference Network on Connective Tissue and Musculoskeletal Diseases, Systemic Lupus International Collaborating Clinics, and the European Lupus Society) previously developed consensus therapeutic strategies for 24 rare SLE manifestations. Here, 77 participants contributed to the development of consensus therapeutic strategies for 22 additional rare SLE manifestations, including diffuse pulmonary haemorrhage, rare cutaneous manifestations (bullous lupus, chilblain lupus, lupus tumidus, erythema multiforme, and toxic epidermal necrolysis-like lupus erythematosus), renal manifestations (interstitial nephritis and lupus podocytopathy), rare neurological manifestations (chorea, small fibre neuropathy, catatonia, and intracranial hypertension), rare gastrointestinal manifestations (protein-losing enteropathy, lupus hepatitis, intestinal pseudo-obstruction, and peritonitis), musculoskeletal manifestations (myositis and Jaccoud's arthropathy), and other rare manifestations such as uveitis, angioedema due to anti-C1 esterase inhibitor antibodies, interstitial cystitis, and lupus mastitis. These expert-based therapeutic strategies provide a framework for guiding therapeutic decisions where evidence-based recommendations might be insufficient.
引用
- Arnaud L, Monticielo OA, Piga M, et al. ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2). Lancet Rheumatol. 2026. PMID: 42648304. doi:10.1016/S2665-9913(26)00141-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。